ProShare Advisors
CNMD icon

ProShare Advisors’s CONMED CNMD Stock Holding History

ProShare Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,058
Closed -$246K – 1903
2025
Q4 		$246K Buy
6,058
+189
+3% +$8.22K ﹤0.01% 1574
2025
Q3 		$276K Sell
5,869
-1,084
-16% -$56.2K ﹤0.01% 1487
2025
Q2 		$362K Sell
6,953
-312
-4% -$17.1K ﹤0.01% 1316
2025
Q1 		$439K Sell
7,265
-2,035
-22% -$131K ﹤0.01% 1168
2024
Q4 		$636K Buy
9,300
+2,865
+45% +$200K ﹤0.01% 1137
2024
Q3 		$463K Buy
6,435
+1,712
+36% +$121K ﹤0.01% 1181
2024
Q2 		$327K Sell
4,723
-1,570
-25% -$115K ﹤0.01% 1225
2024
Q1 		$504K Buy
6,293
+413
+7% +$36.8K ﹤0.01% 1081
2023
Q4 		$644K Buy
5,880
+1,144
+24% +$118K ﹤0.01% 898
2023
Q3 		$478K Sell
4,736
-125
-3% -$14.4K ﹤0.01% 936
2023
Q2 		$661K Buy
4,861
+352
+8% +$43K ﹤0.01% 837
2023
Q1 		$468K Sell
4,509
-126
-3% -$12.2K ﹤0.01% 940
2022
Q4 		$411K Buy
4,635
+595
+15% +$49.4K ﹤0.01% 1059
2022
Q3 		$324K Buy
4,040
+23
+0.6% +$2.17K ﹤0.01% 1102
2022
Q2 		$385K Sell
4,017
-2,447
-38% -$294K ﹤0.01% 1074
2022
Q1 		$959K Sell
6,464
-802
-11% -$112K ﹤0.01% 941
2021
Q4 		$1.03M Buy
7,266
+2,791
+62% +$395K ﹤0.01% 1002
2021
Q3 		$585K Sell
4,475
-3,849
-46% -$504K ﹤0.01% 1111
2021
Q2 		$1.14M Buy
8,324
+204
+3% +$27.9K ﹤0.01% 955
2021
Q1 		$1.06M Buy
8,120
+1,553
+24% +$187K ﹤0.01% 948
2020
Q4 		$736K Buy
6,567
+2,718
+71% +$257K ﹤0.01% 1024
2020
Q3 		$303K Sell
3,849
-323
-8% -$26.3K ﹤0.01% 1167
2020
Q2 		$300K Buy
+4,172
New +$290K ﹤0.01% 1226
2020
Q1 		– Sell
-4,473
Closed -$500K – 1245
2019
Q4 		$500K Buy
4,473
+654
+17% +$69.7K ﹤0.01% 1057
2019
Q3 		$367K Buy
3,819
+402
+12% +$37.7K ﹤0.01% 1117
2019
Q2 		$292K Sell
3,417
-70
-2% -$5.75K ﹤0.01% 1261
2019
Q1 		$290K Buy
3,487
+104
+3% +$7.56K ﹤0.01% 1274
2018
Q4 		$217K Sell
3,383
-355
-9% -$24.3K ﹤0.01% 1333
2018
Q3 		$296K Sell
3,738
-391
-9% -$30.2K ﹤0.01% 1363
2018
Q2 		$302K Sell
4,129
-153
-4% -$10.4K ﹤0.01% 1383
2018
Q1 		$271K Sell
4,282
-550
-11% -$32.8K ﹤0.01% 1375
2017
Q4 		$246K Buy
+4,832
New +$252K ﹤0.01% 1526
2017
Q1 		– Sell
-4,981
Closed -$220K – 1580
2016
Q4 		$220K Buy
+4,981
New +$212K ﹤0.01% 1544
2016
Q1 		– Sell
-4,656
Closed -$205K – 1606
2015
Q4 		$205K Buy
+4,656
New +$202K ﹤0.01% 1530
2015
Q3 		– Sell
-3,982
Closed -$232K – 1469
2015
Q2 		$232K Sell
3,982
-2,016
-34% -$109K ﹤0.01% 1428
2015
Q1 		$303K Sell
5,998
-438
-7% -$21.5K ﹤0.01% 1467
2014
Q4 		$289K Sell
6,436
-4,948
-43% -$207K ﹤0.01% 1545
2014
Q3 		$419K Sell
11,384
-2,807
-20% -$111K 0.01% 1518
2014
Q2 		$627K Sell
14,191
-14,431
-50% -$654K 0.01% 1437
2014
Q1 		$1.24M Buy
+28,622
New +$1.28M 0.02% 1111
2013
Q4 		– Sell
-18,208
Closed -$619K – 1441
2013
Q3 		$619K Sell
18,208
-1,134
-6% -$37K 0.01% 1278
2013
Q2 		$604K Buy
+19,342
New +$628K 0.01% 1180

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

ProShare Advisors's CNMD Position: Q1 2026 in Review

ProShare Advisors sold out of CONMED (CNMD) in Q1 2026, closing a stake of 6,058 shares — an estimated $246K sold.

ProShare Advisors first reported a position in CNMD in Q2 2013 and held it in 42 quarters. The position peaked at $1.24M in Q1 2014. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • ProShare Advisors reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • ProShare Advisors sold 6,058 CONMED shares in Q1 2026, an estimated $246K.
  • ProShare Advisors first reported a position in CONMED in Q2 2013 and held it in 42 quarters.
  • ProShare Advisors's CONMED position peaked at $1.24M in Q1 2014.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.